Management of physical health in patients with schizophrenia

International insights

I. B. Chaudhry, J. Jordan, F. R. Cousin, R. Cavallaro, J. M. Mostaza

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

This international meeting discussed the management of physical health in patients with schizophrenia in several countries including France, Spain, Germany, the UK and Italy. Physical health parameters, including weight, blood pressure, blood glucose, lipids and standard biochemical assessments are measured in many patients at the first hospital consultation. These reveal physical disorders such as obesity, hypertension, dyslipidaemia, the metabolic syndrome, substance abuse, cardiovascular disease, extrapyramidal symptoms, sexual dysfunction and diabetes in substantial proportions of patients. Psychiatrists consider switching antipsychotic therapy if excessive sedation, extrapyramidal symptoms, unacceptable weight gain, hyperglycaemia or dyslipidaemia occur. In general, switching is more likely to be considered for symptomatic adverse events than for laboratory abnormalities. Switching is discouraged by limited knowledge of protocols, the absence of guidelines and fears of relapse or reduced treatment adherence. The physical health of patients with schizophrenia receives much less attention in the community setting than in the hospital setting. Improved guidelines, protocols, resources and support are needed to improve the physical health of patients in the community.

Original languageEnglish
JournalEuropean Psychiatry
Volume25
Issue numberSUPPL. 2
DOIs
Publication statusPublished - Jun 2010

Fingerprint

Schizophrenia
Health
Dyslipidemias
Guidelines
Hyperglycemia
Spain
Italy
Antipsychotic Agents
Weight Gain
France
Fear
Substance-Related Disorders
Germany
Psychiatry
Blood Glucose
Cardiovascular Diseases
Referral and Consultation
Obesity
Blood Pressure
Hypertension

Keywords

  • Antipsychotic therapy
  • Cardiovascular disease
  • Metabolic abnormalities
  • Monitoring
  • Physical health
  • Schizophrenia
  • Weight gain

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Management of physical health in patients with schizophrenia : International insights. / Chaudhry, I. B.; Jordan, J.; Cousin, F. R.; Cavallaro, R.; Mostaza, J. M.

In: European Psychiatry, Vol. 25, No. SUPPL. 2, 06.2010.

Research output: Contribution to journalArticle

Chaudhry, I. B. ; Jordan, J. ; Cousin, F. R. ; Cavallaro, R. ; Mostaza, J. M. / Management of physical health in patients with schizophrenia : International insights. In: European Psychiatry. 2010 ; Vol. 25, No. SUPPL. 2.
@article{53ecf35d110a406f9fb42db828e350a6,
title = "Management of physical health in patients with schizophrenia: International insights",
abstract = "This international meeting discussed the management of physical health in patients with schizophrenia in several countries including France, Spain, Germany, the UK and Italy. Physical health parameters, including weight, blood pressure, blood glucose, lipids and standard biochemical assessments are measured in many patients at the first hospital consultation. These reveal physical disorders such as obesity, hypertension, dyslipidaemia, the metabolic syndrome, substance abuse, cardiovascular disease, extrapyramidal symptoms, sexual dysfunction and diabetes in substantial proportions of patients. Psychiatrists consider switching antipsychotic therapy if excessive sedation, extrapyramidal symptoms, unacceptable weight gain, hyperglycaemia or dyslipidaemia occur. In general, switching is more likely to be considered for symptomatic adverse events than for laboratory abnormalities. Switching is discouraged by limited knowledge of protocols, the absence of guidelines and fears of relapse or reduced treatment adherence. The physical health of patients with schizophrenia receives much less attention in the community setting than in the hospital setting. Improved guidelines, protocols, resources and support are needed to improve the physical health of patients in the community.",
keywords = "Antipsychotic therapy, Cardiovascular disease, Metabolic abnormalities, Monitoring, Physical health, Schizophrenia, Weight gain",
author = "Chaudhry, {I. B.} and J. Jordan and Cousin, {F. R.} and R. Cavallaro and Mostaza, {J. M.}",
year = "2010",
month = "6",
doi = "10.1016/S0924-9338(10)71705-3",
language = "English",
volume = "25",
journal = "Psychiatrie et Psychobiologie",
issn = "0924-9338",
publisher = "Psychiatrie & psychobiologie",
number = "SUPPL. 2",

}

TY - JOUR

T1 - Management of physical health in patients with schizophrenia

T2 - International insights

AU - Chaudhry, I. B.

AU - Jordan, J.

AU - Cousin, F. R.

AU - Cavallaro, R.

AU - Mostaza, J. M.

PY - 2010/6

Y1 - 2010/6

N2 - This international meeting discussed the management of physical health in patients with schizophrenia in several countries including France, Spain, Germany, the UK and Italy. Physical health parameters, including weight, blood pressure, blood glucose, lipids and standard biochemical assessments are measured in many patients at the first hospital consultation. These reveal physical disorders such as obesity, hypertension, dyslipidaemia, the metabolic syndrome, substance abuse, cardiovascular disease, extrapyramidal symptoms, sexual dysfunction and diabetes in substantial proportions of patients. Psychiatrists consider switching antipsychotic therapy if excessive sedation, extrapyramidal symptoms, unacceptable weight gain, hyperglycaemia or dyslipidaemia occur. In general, switching is more likely to be considered for symptomatic adverse events than for laboratory abnormalities. Switching is discouraged by limited knowledge of protocols, the absence of guidelines and fears of relapse or reduced treatment adherence. The physical health of patients with schizophrenia receives much less attention in the community setting than in the hospital setting. Improved guidelines, protocols, resources and support are needed to improve the physical health of patients in the community.

AB - This international meeting discussed the management of physical health in patients with schizophrenia in several countries including France, Spain, Germany, the UK and Italy. Physical health parameters, including weight, blood pressure, blood glucose, lipids and standard biochemical assessments are measured in many patients at the first hospital consultation. These reveal physical disorders such as obesity, hypertension, dyslipidaemia, the metabolic syndrome, substance abuse, cardiovascular disease, extrapyramidal symptoms, sexual dysfunction and diabetes in substantial proportions of patients. Psychiatrists consider switching antipsychotic therapy if excessive sedation, extrapyramidal symptoms, unacceptable weight gain, hyperglycaemia or dyslipidaemia occur. In general, switching is more likely to be considered for symptomatic adverse events than for laboratory abnormalities. Switching is discouraged by limited knowledge of protocols, the absence of guidelines and fears of relapse or reduced treatment adherence. The physical health of patients with schizophrenia receives much less attention in the community setting than in the hospital setting. Improved guidelines, protocols, resources and support are needed to improve the physical health of patients in the community.

KW - Antipsychotic therapy

KW - Cardiovascular disease

KW - Metabolic abnormalities

KW - Monitoring

KW - Physical health

KW - Schizophrenia

KW - Weight gain

UR - http://www.scopus.com/inward/record.url?scp=77954147514&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954147514&partnerID=8YFLogxK

U2 - 10.1016/S0924-9338(10)71705-3

DO - 10.1016/S0924-9338(10)71705-3

M3 - Article

VL - 25

JO - Psychiatrie et Psychobiologie

JF - Psychiatrie et Psychobiologie

SN - 0924-9338

IS - SUPPL. 2

ER -